Selecting patient-reported outcome measures for a patient-facing technology.

ABSTRACT:

Objective

This article provides insight into our process and considerations for selecting patient-reported outcome measures (PROMs) designed for self-reporting symptoms and quality-of-life among breast cancer (BCA) patients undergoing oral anticancer agent treatment via a patient-facing technology (PFT) platform.

Methods

Following established guidelines, we conducted a thorough assessment of a specific set of PROMs, comparing their content to identify the most suitable options for studying BCA patients.

Results

We recommend utilizing the combination of EORTC QLQ-C30 + EORTC QLQ-BR45 as the preferred instrument, especially when developing a dedicated "breast cancer-only" application.

Discussion

When developing and maintaining a dashboard for a PFT platform that

SUBMITTER: Raj P 

PROVIDER: S-EPMC10719077 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature